Issue published 30 December 2025 Abstract Background: To determine whether initiating a glucagon-like peptide-1 receptor agonist (GLP-1 RA) within 3 months of type 2 diabetes (T2DM) diagnosis alters the subsequent risk of overall and site-specific cancer and whether this association differs by baseline body-mass index (BMI)
Managing Efficacy and Side Effects Throughout the Week Because GLP-1 concentration peaks early in the week and gradually declines, many patients notice stronger appetite suppression on days 1 through 4 after injection, with a gentler effect by days 6 and 7
In our clinical trials, DPSC transplantation exhibited a safety profile consistent with our previous animal studies
Written by: Robert Goldfaden and Gary Goldfaden, MD
Biesalski HK: Vitamine, Spurenelemente und Minerale
GLP-1 medications also slow gastric emptying, which can worsen acid reflux in some people, bringing acid into contact with teeth even without vomiting